Amarantus BioScience Holdings, Inc.
AMBS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $1 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $31 | $31 | $31 | $31 |
| Total Curr. Assets | $31 | $31 | $31 | $31 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $1 | $1 |
| Long-Term Investments | $10,176 | $14,674 | $24,841 | $24,753 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $10,177 | $14,675 | $24,842 | $24,754 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $10,208 | $14,707 | $24,873 | $24,786 |
| Liabilities | – | – | – | – |
| Payables | $15,309 | $15,440 | $15,156 | $14,604 |
| Short-Term Debt | $19,139 | $19,193 | $19,201 | $19,138 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $424 | $0 | $0 | $0 |
| Total Curr. Liab. | $34,873 | $34,633 | $34,357 | $33,741 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $34,873 | $34,633 | $34,357 | $33,741 |
| Equity | – | – | – | – |
| Pref Stock | $1,533 | $1,533 | $1,533 | $1,553 |
| Common Stock | $293 | $282 | $272 | $261 |
| Retained Earnings | -$106,474 | -$101,652 | -$91,247 | -$90,619 |
| AOCI | -$293 | -$282 | -$272 | -$261 |
| Other Equity | $80,276 | $80,193 | $80,230 | $80,110 |
| Total Equity | -$24,665 | -$19,926 | -$9,484 | -$8,956 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10,208 | $14,707 | $24,873 | $24,786 |
| Net Debt | $19,139 | $19,192 | $19,201 | $19,137 |